Adagene (ADAG) Competitors $2.05 0.00 (0.00%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends ADAG vs. MBX, RGNX, TSHA, TRVI, ATYR, TERN, TRML, CYRX, ACB, and ATAIShould you be buying Adagene stock or one of its competitors? The main competitors of Adagene include MBX Biosciences (MBX), REGENXBIO (RGNX), Taysha Gene Therapies (TSHA), Trevi Therapeutics (TRVI), Atyr PHARMA (ATYR), Terns Pharmaceuticals (TERN), Tourmaline Bio (TRML), Cryoport (CYRX), Aurora Cannabis (ACB), and Atai Life Sciences (ATAI). These companies are all part of the "pharmaceutical products" industry. Adagene vs. MBX Biosciences REGENXBIO Taysha Gene Therapies Trevi Therapeutics Atyr PHARMA Terns Pharmaceuticals Tourmaline Bio Cryoport Aurora Cannabis Atai Life Sciences Adagene (NASDAQ:ADAG) and MBX Biosciences (NYSE:MBX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, risk and dividends. Do institutionals & insiders believe in ADAG or MBX? 9.5% of Adagene shares are held by institutional investors. 21.2% of Adagene shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is ADAG or MBX more profitable? Company Net Margins Return on Equity Return on Assets AdageneN/A N/A N/A MBX Biosciences N/A N/A N/A Does the MarketBeat Community prefer ADAG or MBX? Adagene received 18 more outperform votes than MBX Biosciences when rated by MarketBeat users. However, 100.00% of users gave MBX Biosciences an outperform vote while only 78.57% of users gave Adagene an outperform vote. CompanyUnderperformOutperformAdageneOutperform Votes2278.57% Underperform Votes621.43% MBX BiosciencesOutperform Votes4100.00% Underperform VotesNo Votes Do analysts recommend ADAG or MBX? Adagene currently has a consensus target price of $8.00, suggesting a potential upside of 290.24%. MBX Biosciences has a consensus target price of $37.25, suggesting a potential upside of 250.72%. Given Adagene's higher possible upside, equities analysts plainly believe Adagene is more favorable than MBX Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adagene 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50MBX Biosciences 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, ADAG or MBX? MBX Biosciences has lower revenue, but higher earnings than Adagene. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdagene$815.75K111.25-$18.95MN/AN/AMBX BiosciencesN/AN/AN/AN/AN/A Does the media refer more to ADAG or MBX? In the previous week, Adagene had 2 more articles in the media than MBX Biosciences. MarketBeat recorded 4 mentions for Adagene and 2 mentions for MBX Biosciences. Adagene's average media sentiment score of 0.77 beat MBX Biosciences' score of 0.00 indicating that Adagene is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adagene 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MBX Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAdagene beats MBX Biosciences on 7 of the 10 factors compared between the two stocks. Get Adagene News Delivered to You Automatically Sign up to receive the latest news and ratings for ADAG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADAG vs. The Competition Export to ExcelMetricAdagenePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$90.76M$7.21B$5.80B$8.35BDividend YieldN/A2.80%4.76%3.97%P/E RatioN/A6.2024.9219.12Price / Sales111.25188.49374.24113.03Price / CashN/A65.6738.0534.62Price / Book1.276.417.314.26Net Income-$18.95M$139.72M$3.19B$246.62M7 Day Performance1.99%-3.40%-3.20%-3.75%1 Month Performance10.51%-9.16%-7.06%-6.89%1 Year Performance-33.87%-12.87%12.06%3.39% Adagene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADAGAdagene1.9899 of 5 stars$2.05flat$8.00+290.2%-37.5%$90.76M$815,746.000.00260Gap DownMBXMBX Biosciences1.7061 of 5 stars$10.36-4.8%$37.25+259.6%N/A$346.20MN/A0.0036News CoveragePositive NewsGap DownRGNXREGENXBIO4.3835 of 5 stars$6.93-4.7%$33.45+382.7%-72.1%$343.35M$84.33M-1.38370Gap DownTSHATaysha Gene Therapies2.4506 of 5 stars$1.65+2.5%$6.63+301.5%-49.8%$338.15M$15.45M2.62180Earnings ReportAnalyst RevisionTRVITrevi Therapeutics3.0107 of 5 stars$4.31-6.3%$9.31+116.1%+45.4%$331.31MN/A-9.8020High Trading VolumeATYRAtyr PHARMA2.8025 of 5 stars$3.83-11.3%$18.60+385.6%N/A$321.49M$350,000.00-4.0753TERNTerns Pharmaceuticals4.5708 of 5 stars$3.73-7.0%$18.30+390.6%-53.6%$316.83MN/A-3.1640TRMLTourmaline Bio2.4163 of 5 stars$12.25+0.3%$54.67+346.3%-71.0%$314.13MN/A-4.3444Gap UpCYRXCryoport2.318 of 5 stars$6.33+1.8%$12.29+94.1%-73.2%$312.90M$226.11M-1.871,170ACBAurora Cannabis1.257 of 5 stars$5.61-4.8%N/A+53.0%$307.75M$320.81M112.221,073Positive NewsGap DownATAIAtai Life Sciences3.1586 of 5 stars$1.82-8.5%$9.00+394.5%-29.6%$305.40M$331,000.00-2.2580 Related Companies and Tools Related Companies MBX Competitors RGNX Competitors TSHA Competitors TRVI Competitors ATYR Competitors TERN Competitors TRML Competitors CYRX Competitors ACB Competitors ATAI Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ADAG) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adagene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adagene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
